These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 39273062)
1. Emerging and Biological Concepts in Pediatric High-Grade Gliomas. Yoel A; Adjumain S; Liang Y; Daniel P; Firestein R; Tsui V Cells; 2024 Sep; 13(17):. PubMed ID: 39273062 [TBL] [Abstract][Full Text] [Related]
2. Pediatric hemispheric high-grade glioma: targeting the future. Coleman C; Stoller S; Grotzer M; Stucklin AG; Nazarian J; Mueller S Cancer Metastasis Rev; 2020 Mar; 39(1):245-260. PubMed ID: 31989507 [TBL] [Abstract][Full Text] [Related]
3. [Pediatric-Type Diffuse High-Grade Gliomas]. Natsumeda M No Shinkei Geka; 2023 Sep; 51(5):876-883. PubMed ID: 37743339 [TBL] [Abstract][Full Text] [Related]
4. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review. Thomas DL Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356 [TBL] [Abstract][Full Text] [Related]
5. H3 G34-mutant high-grade glioma. Lim KY; Won JK; Park CK; Kim SK; Choi SH; Kim T; Yun H; Park SH Brain Tumor Pathol; 2021 Jan; 38(1):4-13. PubMed ID: 32995948 [TBL] [Abstract][Full Text] [Related]
6. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies. Bonada M; Pittarello M; De Fazio E; Gans A; Alimonti P; Slika H; Legnani F; Di Meco F; Tyler B Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202398 [TBL] [Abstract][Full Text] [Related]
7. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres. La Rocca G; Sabatino G; Altieri R; Signorelli F; Ricciardi L; Gessi M; Della Pepa GM World Neurosurg; 2019 Nov; 131():174-176. PubMed ID: 31415896 [TBL] [Abstract][Full Text] [Related]
8. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894 [TBL] [Abstract][Full Text] [Related]
9. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas. Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603 [TBL] [Abstract][Full Text] [Related]
10. Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification. Gianno F; Giovannoni I; Cafferata B; Diomedi-Camassei F; Minasi S; Barresi S; Buttarelli FR; Alesi V; Cardoni A; Antonelli M; Puggioni C; Colafati GS; Carai A; Vinci M; Mastronuzzi A; Miele E; Alaggio R; Giangaspero F; Rossi S Pathologica; 2022 Dec; 114(6):422-435. PubMed ID: 36534421 [TBL] [Abstract][Full Text] [Related]
11. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management. Sturm D; Pfister SM; Jones DTW J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698 [TBL] [Abstract][Full Text] [Related]
12. Pediatric high grade gliomas: A comprehensive histopathological, immunohistochemical and molecular integrated approach in routine practice. Das S; Ahlawat S; Panda AK; Sarangi J; Jain P; Gupta RK; Vaishya S; Patir R Pathol Res Pract; 2024 Jun; 258():155347. PubMed ID: 38763090 [TBL] [Abstract][Full Text] [Related]
14. Histone H3.3 G34-mutant Diffuse Gliomas in Adults. Wang L; Shao L; Li H; Yao K; Duan Z; Zhi C; Song S; Cheng Y; Wang F; Wang W; Piao Y; Gui Q; Lu D; Qi X; Teng L Am J Surg Pathol; 2022 Feb; 46(2):249-257. PubMed ID: 34352809 [TBL] [Abstract][Full Text] [Related]
16. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101 [TBL] [Abstract][Full Text] [Related]
17. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847 [TBL] [Abstract][Full Text] [Related]
19. Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases. Kibe Y; Ohka F; Aoki K; Yamaguchi J; Motomura K; Ito E; Takeuchi K; Nagata Y; Ito S; Mizutani N; Shiba Y; Maeda S; Nishikawa T; Shimizu H; Saito R Acta Neuropathol Commun; 2024 Apr; 12(1):57. PubMed ID: 38605367 [TBL] [Abstract][Full Text] [Related]